Zomedica Corp. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Zomedica Corp. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2017 to Q3 2024.
  • Zomedica Corp. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 980M shares, unchanged year-over-year.
  • Zomedica Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 980M shares, unchanged from 2022.
  • Zomedica Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 980M shares, a 2.45% increase from 2021.
  • Zomedica Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 957M shares, a 162% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 980M 0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 980M 0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 980M 0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 980M 0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 980M 0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 980M +50K +0.01% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 980M +50K +0.01% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 980M +23.4M +2.45% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 980M +1.46M +0.15% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 980M +6.24M +0.64% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 980M +89.7M +10.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 957M +592M +162% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 978M +428M +77.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 974M +759M +353% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 890M +772M +652% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 364M +258M +243% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 551M +443M +410% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 215M +107M +98.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 118M +17.5M +17.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 106M +12.9M +13.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 108M +13.5M +14.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 108M +15.5M +16.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 101M +10.3M +11.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 93.4M +6.04M +6.91% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 94.5M +5.67M +6.38% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 92.5M +5.45M +6.26% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 90.5M +6.1M +7.23% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 87.4M Oct 1, 2017 Dec 31, 2017 10-K/A 2019-03-14
Q3 2017 88.8M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 87.1M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 84.4M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.